Safety Evaluation of Recombinant Human Interleukin-4

This publication has 26 references indexed in Scilit:

• Safety Evaluation of Recombinant Human Interleukin-4
  Clinical Immunology and Immunopathology, 1997
• Systemic treatment with interleukin-4 induces regression of pulmonary metastases in a murine renal cell carcinoma model
  Cellular Immunology, 1995
• The eosinophil-mediated antitumor activity of interleukin-4
  Journal of Allergy and Clinical Immunology, 1994
• Interleukin 4 inhibits the production of some acute‐phase proteins by human hepatocytes in primary culture
  FEBS Letters, 1993
• Clinical Pathologic Alterations Associated with Subcutaneous Administration of Recombinant Human Interleukin-4 to Cynomolgus Monkeys
  Toxicologic Pathology, 1993
• Preclinical evaluation of recombinant human interleukin-4
  Toxicology Letters, 1992
• Interleukin‐4 stimulates collagen gene expression in human fibroblast monolayer cultures Potential role in fibrosis
  FEBS Letters, 1992
• Pre-clinical toxicity of Il-4: A model for studying protein therapeutics
  International Journal of Immunopharmacology, 1992
• Histomorphologic Observations for Cynomolgus Monkeys after Subchronic Subcutaneous Injection of Recombinant Human Interleukin-4
  Toxicologic Pathology, 1991
• Interleukin-4 is a potent mitogen for capillary endothelium
  Biochemical and Biophysical Research Communications, 1991